๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Indications for primary tamoxifen therapy in elderly women with breast cancer

โœ Scribed by D. J. Gaskell; R. A. Hawkins; S. De Carteret; U. Chetty; K. Sangster; Professor Sir A. P. M. Forrest

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
402 KB
Volume
79
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Gamma linolenic acid with tamoxifen as p
Gamma linolenic acid with tamoxifen as primary therapy in breast cancer
โœ Frances S. Kenny; Sarah E. Pinder; Ian O. Ellis; Julia M.W. Gee; Robert I. Nicho ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 112 KB ๐Ÿ‘ 2 views

Gamma linolenic acid (GLA) has been proposed as a valuable new cancer therapy having selective anti-tumour properties with negligible systemic toxicity. Proposed mechanisms of action include modulation of steroid hormone receptors. We have investigated the effects of GLA with primary hormone therapy

Combined endocrine effects of LHRH agoni
Combined endocrine effects of LHRH agonist (Zoladexยฎ) and tamoxifen (Nolvadexยฎ) therapy in premenopausal women with breast cancer
โœ Mr J. F. R. Robertson; K. J. Walker; R. I. Nicholson; R. W. Blamey ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 355 KB

Abstract In premenopausal women with breast cancer, the use of the luteinizing hormone releasing hormone agonist, goserelin, results in the production of serum levels of oestradiol equivalent to those after surgical oรถphorectomy or in postmenopausal women. The standard first line hormonal treatment